Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.
Innovative Medicines
Made up of two business units, Novartis Pharmaceuticals which includes Novartis Gene Therapies, and Novartis Oncology & our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.
Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
1859
Served areaWorldwide
Headcount110,000
HeadquartersLichtstrasse 35, 4002 Basel – Switzerland
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
12.06.23 | None | Executive member | Sell | CHF 260,113.56 |
16.05.23 | None | Executive member | Sell | CHF 1,200,359.19 |
23.05.22 | None | Executive member | Sell | CHF 84,085.12 |
27.04.22 | None | Executive member | Sell | CHF 1,765,600.80 |
04.03.22 | None | Non-Executive member | Buy | CHF 195,000.00 |
04.03.22 | None | Non-Executive member | Buy | CHF 180,000.00 |
28.02.22 | None | Executive member | Sell | CHF 80,880.00 |
25.02.22 | None | Executive member | Sell | CHF 16,076.00 |
22.02.22 | None | Executive member | Sell | CHF 47,451.25 |
21.02.22 | None | Executive member | Sell | CHF 1.00 |
CH0012005267
LEI5493007HIVTX6SY6XD66
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustrySMI
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.